California Life Sciences featured in Big4Bio’s first Pivot Report exploring Diversity, Equity, and Inclusion
Back
California Life Sciences is proud to be featured in Big4Bio’s first Pivot Report exploring Diversity, Equity, and Inclusion! We share what CLS is doing differently to make real impact, how we feel DEI efforts are progressing, and how our industry can improve.
Big4Bio: How is CLS embracing inclusion, diversity, equity, and access?
California Life Sciences: CLS launched the Racial & Social Equity Initiative (RSE) in March 2021. This is our bold plan to commit to change — a unified effort to do more for the historically excluded Black, Indigenous, and all People of Color (BIPOC) populations in California. We’re partnering with more than 80 organizations to create diverse boards, empower and invest in diverse innovators and entrepreneurs, develop BIPOC talent to fuel our innovation pipeline, and improve health equity for underserved communities. CLS has raised close to $3M to fund these efforts.
The Racial & Social Equity Initiative is our bold plan to commit to change, a unified effort to do more for the historically excluded Black, Indigenous and other People of Color (BIPOC) populations in California. Learn more about our efforts and join us.